Data de publicació 16/09/20 15:25
Introduction to Biosimilar
Factors contributing to rapid growth of Biosimilar sector.
A decade ago, the global pharmaceutical market was dominated by small molecule drugs. However, complex molecule drugs or biologics have now gained a significant market share. In 2019, it was not small molecule but a biologic, Humira (adalimumab), which clocked sale of US$ 19.9...